Increased expression of histone proteins during estrogen-mediated cell proliferation.
AffiliationImperial College London
MetadataShow full item record
AbstractThere is concern about the potential risk posed by compounds with estrogen-like activity present in the environment. As previous studies have shown that combined exposure to such compounds results in dose additivity, it should be possible to assess estrogen exposure with suitable biomarkers of effect.
CitationZhu, Z., Edwards, R.J., Boobis, A.R. (2009) 'Increased expression of histone proteins during estrogen-mediated cell proliferation' Environmental Health Perspectives 117 (6):928-934
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/
- Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
- Authors: Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M
- Issue date: 2002 Sep 1
- Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
- Authors: Rajah TT, Du N, Drews N, Cohn R
- Issue date: 2009
- Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
- Authors: Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS
- Issue date: 2008 May
- Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
- Authors: Treeck O, Lattrich C, Springwald A, Ortmann O
- Issue date: 2010 Apr
- Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type.
- Authors: Lima F, Vico L, Lafage-Proust MH, van der Saag P, Alexandre C, Thomas T
- Issue date: 2004 Nov